Nuclera
Address: One Vision Park, Station Rd,, Impington, Cambridge, CB24 9NPAbout Us
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system. Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
Sectors
- Equipment & Machinery
- Collaborations & Partnerships- R&D
- Collaborations & Partnerships-Services
- Collaborations & Partnerships-Manufacture
- Contract Research & Development
- Contract Manufacturing
Categories
- Equipment & Machinery
- Drug Discovery Services
- Proteins
- Proteins-Recombinant
- Bioprocess Development
- Bioprocessing
- Laboratory Equipment
- Drug Design
News
Nuclera and Cytiva Join Forces to Accelerate Drug Discovery
At Nuclera, we’re driven by a single goal: to revolutionize protein expression and optimization. That’s why we’re excited to share news of our latest collaboration with Cytiva, a global leader in life sciences. Together, we’re streamlining the production, purification, and characterization of proteins essential for drug research and development—bringing new efficiencies to a process that has traditionally taken months.
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com